'Wegovy' weight loss drug could improve heart failure symptoms
The weight loss medication semaglutide – better known as Wegovy – can benefit people living with heart failure and obesity, according to research presented today at the European Society of Cardiology (ESC) Congress in Amsterdam and published in the New England Journal of Medicine.